Abstract
Staphylococci, particularly methicillin-resistant strains of Staphylococcus aureus, are major nosocomial pathogens in large hospitals in eastern Australia. At present vancomycin is the drug of choice for the treatment of life-threatening methicillin-resistant S. aureus infections. A possible alternative drug is coumermycin, a bis-hydroxy coumarin which inhibits DNA gyrase. Coumermycin activity was determined against clinical isolates from the Royal Melbourne Hospital. MICs of 639 staphylococcal isolates were determined by agar dilution. MICs and MBCs of 100 staphylococcal isolates were also determined by microdilution methods. The results showed that coumermycin was bactericidal, with MBCs of less than or equal to 4 micrograms/ml against all isolates tested. The results indicate that coumermycin is a potential alternative to vancomycin in the treatment of severe staphylococcal infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Farber B. B. Vancomycin: renewed interest in an old drug. Eur J Clin Microbiol. 1984 Feb;3(1):1–3. doi: 10.1007/BF02032805. [DOI] [PubMed] [Google Scholar]
- Kaplan S. A. Pharmacokinetic profile of coumermycin A. J Pharm Sci. 1970 Mar;59(3):309–313. doi: 10.1002/jps.2600590306. [DOI] [PubMed] [Google Scholar]
- McDonald M., Hurse A., Sim K. N. Methicillin-resistant Staphylococcus aureus bacteraemia. Med J Aust. 1981 Aug 22;2(4):191–194. doi: 10.5694/j.1326-5377.1981.tb100894.x. [DOI] [PubMed] [Google Scholar]
- McDonald P. J. Methicillin-resistant staphylococci: a sign of the times? Med J Aust. 1982 May 29;1(11):445–446. [PubMed] [Google Scholar]
- Michaeli D., Meyers B., Weinstein L. In vitro studies of the activity of coumermycin-A1 against staphylococci resistant to methicillin and cephalothin. J Infect Dis. 1969 Oct;120(4):488–490. doi: 10.1093/infdis/120.4.488. [DOI] [PubMed] [Google Scholar]
- Newmark H. L., Berger J. Coumermycin A-biopharmaceutical studies. I. J Pharm Sci. 1970 Sep;59(9):1246–1248. doi: 10.1002/jps.2600590905. [DOI] [PubMed] [Google Scholar]
- Pavillard R., Harvey K., Douglas D., Hewstone A., Andrew J., Collopy B., Asche V., Carson P., Davidson A., Gilbert G. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust. 1982 May 29;1(11):451–454. [PubMed] [Google Scholar]
- Townsend D. E., Ashdown N., Pearman J. W., Annear D. I., Grubb W. B. Genetics and epidemiology of methicillin-resistant Staphylococcus aureus isolated in a Western Australian hospital. Med J Aust. 1985 Jan 21;142(2):108–111. doi: 10.5694/j.1326-5377.1985.tb133045.x. [DOI] [PubMed] [Google Scholar]
- Traber P. G., Levine D. P. Vancomycin Ototoxicity in patient with normal renal function. Ann Intern Med. 1981 Oct;95(4):458–460. doi: 10.7326/0003-4819-95-4-458. [DOI] [PubMed] [Google Scholar]